Purchase Order 75N94022P00681
Award Date
8/19/22
Potential Completion Date
8/18/23
Potential Value
$69K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Olink Proteomics AB
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sweden
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation...
This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to the prime contractor Olink Proteomics AB, a foreign-owned for-profit organization. The contract is for $248,950.00 and is for the OLINK EXPLORE EXPANSION (4) requirement, which includes the provision of Olink's proprietary multiplex protein biomarker analysis technologies and platforms to support biomedical research. The contract has a firm fixed...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $10,558 firm-fixed-price purchase order is for the delivery of Olink's proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical research missions spanning aging, cancer, neurodegenerative diseases, diabetes, infectious diseases, and more. Olink...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for the provision of the OLINK SIGNATURE Q100 STARTER KIT AND REAGENTS. The contract is a firm-fixed-price purchase order with a potential value of $187,601.80 and a completion date of August 22, 2023. No set-aside designation was used for this award. Olink Proteomics has received...
This firm fixed price purchase order contract was awarded by the Food and Drug Administration (FDA) to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $75,718 contract is for the provision of proteomics analysis services, including the analysis of plasma samples to support biomedical research across disease areas such as cancer, cardiovascular disease, infectious disease, and COVID-19. Olink has previously provided similar services to federal agencies like the...
This is a firm-fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the Department of Health and Human Services (HHS). The contract, with a ceiling value of $84,480.00, was awarded to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, to provide laboratory testing services. The contract has no set-aside designation. Olink Proteomics specializes in proteomics instruments, reagents, and...
This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...